REQUEST A DEMO
Total
USD $0.00
Search more companies

Mediplast Cz, S.R.O. (Czech Republic)

Main Activities: Medical Equipment and Supplies Manufacturing
Full name: Mediplast Cz, S.R.O. Profile Updated: November 10, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Mediplast Cz, S.R.O. is an enterprise in Czech Republic, with the main office in Prague. The enterprise currently operates in the Medical Equipment and Supplies Manufacturing sector. It was first established on August 25, 2004. It currently has a total number of 6 - 9 (2024) employees. In its most recent financial highlights, the company reported a net sales revenue drop of 8.59% in 2023. Its’ total assets recorded a growth of 18.97%. Mediplast Cz, S.R.O.’s net profit margin increased by 9.44% in 2023.

Headquarters
Konojedska 1556/19
Prague; The City of Prague; Postal Code: 10000

Contact Details: Purchase the Mediplast Cz, S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Mediplast Cz, S.R.O. report to view the information.
Outstanding Shares:
Purchase the Mediplast Cz, S.R.O. report to view the information.
Registered Capital:
Purchase the Mediplast Cz, S.R.O. report to view the information.
Incorporation Date:
August 25, 2004
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
60%
Company Performance
Financial values in the chart are available after Mediplast Cz, S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
-8.59%
Total operating revenue
1.71%
Operating profit (EBIT)
164.43%
EBITDA
48%
Net Profit (Loss) for the Period
284.34%
Total assets
18.97%
Total equity
15.8%
Operating Profit Margin (ROS)
8.4%
Net Profit Margin
9.44%
Return on Equity (ROE)
9.54%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?